AZD5904
CAS No. 618913-30-7
AZD5904 ( AZD 5904;AZD-5904 )
产品货号. M15342 CAS No. 618913-30-7
AZD5904 (AZD-5904) is a potent, selective irreversible, orally bioavailable myeloperoxidase (MPO) inhibitor with IC50 of 140 nM.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥551 | 有现货 |
|
5MG | ¥915 | 有现货 |
|
10MG | ¥1256 | 有现货 |
|
25MG | ¥2535 | 有现货 |
|
50MG | ¥4560 | 有现货 |
|
100MG | ¥6577 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称AZD5904
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述AZD5904 (AZD-5904) is a potent, selective irreversible, orally bioavailable myeloperoxidase (MPO) inhibitor with IC50 of 140 nM.
-
产品描述AZD5904 (AZD-5904) is a potent, selective irreversible, orally bioavailable myeloperoxidase (MPO) inhibitor with IC50 of 140 nM, similar potency in mouse and rat; displays 10 to 19-fold selective compared to the closely related lactoperoxidase and thyroid peroxidase, >70-fold to a broad panel of other enzymes, ion channels, and receptors; 1 μM AZD5904 inhibited PMA stimulated HOCl by >90% in isolated human neutrophils; a plasma concentration of ~5 μM decreased the in vivo formation of glutathione sulphonamide in rats.Multiple Sclerosis Phase 1 Discontinued
-
同义词AZD 5904;AZD-5904
-
通路Others
-
靶点Other Targets
-
受体Other Targets
-
研究领域Inflammation/Immunology
-
适应症Multiple Sclerosis
化学信息
-
CAS Number618913-30-7
-
分子量252.29
-
分子式C10H12N4O2S
-
纯度>98% (HPLC)
-
溶解度DMSO : 125 mg/mL 495.46 mM
-
SMILESO=C1NC(N(C[C@H]2OCCC2)C3=C1NC=N3)=S
-
化学全称6H-Purin-6-one, 1,2,3,7-tetrahydro-3-[[(2R)-tetrahydro-2-furanyl]methyl]-2-thioxo- (9CI)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Metaxalone
Metaxalone (marketed by King Pharmaceuticals under the brand name Skelaxin ) is a muscle relaxant used to relax muscles and relieve pain caused by strains, sprains, and other musculoskeletal conditions.
-
Zanthobungeanine
Zanthobungeanine has anti-inflammatory activity, it shows moderate NO production inhibitory activity with an IC50 value of 37.26 mg /L.It shows obviously inhibitoryactivity to platelet aggregation caused by platelet-activating factor (PAF). Zanthobungeanine shows the inhibitory action on the development of A549 cell only in high concentration and has no antipersonnel effect on A549 cell.
-
Dibutylurea
Used as pharmaceutical intermediates.